We provide you with 20 years of free, institutional-grade data for ANVS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ANVS. Explore the full financial landscape of ANVS stock.
| Reported Date | CIK | Ticker | Type |
|---|
Annovis Bio, Inc(NYSE:ANVS) 
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chron...
Website: http://www.qrpharma.com
Founded: 2008
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about ANVS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.